Experimental manipulation of the gut microbiome was found to modify emotional and cognitive behavior, neurotransmitter expression and brain function in rodents, but corresponding human data remain scarce. The present double-blind, placebo-controlled randomised study aimed at investigating the effects of 4 weeks’ probiotic administration on behavior, brain function and gut microbial composition in healthy volunteers. Forty-five healthy participants divided equally into three groups (probiotic, placebo and no intervention) underwent functional MRI (emotional decision-making and emotional recognition memory tasks). In addition, stool samples were collected to investigate the gut microbial composition. Probiotic administration for 4 weeks was associated with changes in brain activation patterns in response to emotional memory and emotional decision-making tasks, which were also accompanied by subtle shifts in gut microbiome profile. Microbiome composition mirrored self-reported behavioral measures and memory performance. This is the first study reporting a distinct influence of probiotic administration at behavioral, neural, and microbiome levels at the same time in healthy volunteers. The findings provide a basis for future investigations into the role of the gut microbiota and potential therapeutic application of probiotics.
This work provides new insights into the role of a multi-strain probiotic administration in modulating the behaviour, which is reflected as changes in the FC in healthy volunteers. This study motivates future investigations into the role of probiotics in context of major depression and stress disorders.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Three‐dimensional (3D) human heart imaging at ultra‐high fields is highly challenging due to respiratory and cardiac motion‐induced artifacts as well as spatially heterogeneous
B1+0.25em profiles. In this study, we investigate the feasibility of applying 3D flip angle (FA) homogenization targeting the whole heart via static phase‐only and dynamic kT‐point in vivo parallel transmission at 7 T. 3D
B1+ maps of the thorax were acquired under free breathing in eight subjects to compute parallel transmission pulses that improve excitation homogeneity in the human heart. To analyze the number of kT‐points required, excitation homogeneity and radiofrequency (RF) power were compared using different regions of interest in six subjects with different body mass index (BMI) values of 20‐34 kg/m2 for a wide range of regularization parameters. One subset of the optimized subject‐specific pulses was applied in vivo on a 7 T scanner for six subjects in Cartesian 3D breath‐hold scans as well as in two subjects in a radial phase‐encoded 3D free‐breathing scan. Across all subjects, 3‐4 kT‐points achieved a good tradeoff between RF power and nominal FA homogeneity. For subjects with a BMI in the normal range, the 4 kT‐point pulses reliably improved the coefficient of variation by less than 10% compared with less than 25% achieved by static phase‐only parallel transmission. in vivo measurements on a 7 T scanner validated the
B1+0.25em estimations and the pulse design, despite neglecting ΔB0 in the optimizations and Bloch simulations. This study demonstrates in vivo that kT‐point pTx pulses are highly suitable for mitigating nominal FA heterogeneities across the entire 3D heart volume at 7 T. Furthermore, 3‐4 kT‐points demonstrate a practical tradeoff between nominal FA heterogeneity mitigation and RF power.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.